2025 Mar 14, 20:42
Wegovy, a weight loss drug that was discovered accidentally while manufacturing insulin, has become increasingly popular for treating obesity in the UK. It can be obtained through a prescription at the regular price or purchased for approximately £295 from pharmacies like Superdrug. The drug has gained traction in celebrity circles, with high-profile figures such as Elon Musk, Sharon Osbourne, and several Kardashians attributing their sudden weight loss to its use. Novo Nordisk, the company that manufactures Wegovy, is responsible for half of the world's insulin supply. The CEO of Novo Nordisk, Lars Fruergaard Jørgensen, is described as "tall, thin, and thoughtful," and has been with the company since 1991
Known for his ambition, accountability, and respectful treatment of others, Jørgensen embodies both Danish culture and a global perspective. Novo Nordisk's steady rise to success has been mirrored by Jørgensen's low-key approach to leadership. He is often referred to as "the listening leader" due to his willingness to listen to and understand the motivations of those he works with. Despite his humble nature, Jørgensen aims to make a significant impact in the industry. Jørgensen's patient and persistent approach to innovation was praised by the Financial Times
Compared to other high-profile CEOs like Bernard Arnault of LVMH, Jørgensen stands out for his commitment to transformational innovation. Unlike Arnault, who sold his private jet following scrutiny, Jørgensen chooses to fly commercial, despite earning a substantial salary and overseeing a global staff of 42,000. Jørgensen attributes his humility to his upbringing on a family farm in central Denmark, where he learned patience and perseverance. According to Jørgensen's close friend, Bent Dalager, growing up on a farm instilled in him the mindset of sowing seeds for future growth, much like the research into weight loss drugs in the pharmaceutical industry.